Janssen launches global health unit

Share this article:

Johnson & Johnson's Janssen division has launched a global public health group. Janssen said in its Thursday announcement that the new division will unify Janssen's “commitment to research, develop and deliver transformational medicines to address the world's greatest unmet public health needs.”

Paul Stoffels, who is chief scientific officer of J&J and worldwide chairman of Janssen, said in a statement that the new unit gives the company "a more focused approach to further develop and introduce our most promising medicines."

The unit is also charged with increasing medication access and will build on and incorporate practices from Janssen's global access and partnerships program, which is focused on increasing access to HIV medications.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.